Drug
Pittsburgh compound B clinical trials
Includes 3 studies of PIB C-11.
- studies test it
- 16
- open now
- 4
- in phase 3
- 0
- first study started
- 2008
Keep track of what changes. Save the Pittsburgh compound B studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2012 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 7
- Phase 2
- 4
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 15
Mayo Clinic (7) · University of North Carolina, Chapel Hill (1) · Vanderbilt University Medical Center (1) · University of Pittsburgh (1) · Johns Hopkins University (1) · Avid Radiopharmaceuticals (1) · Peking Union Medical College Hospital (1) · National Institute of Mental Health (NIMH) (1)
Often tested with
Tested in the same studies.
Florbetapir (1) · Flortaucipir (1) · ER-176 C-11 (1) · Florquinitau F-18 (1)
Studies
Open first, then newest update. How each study uses Pittsburgh compound B is read from its arms, and is right about nine times in ten.
Testing it · 16
- Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CARecruitingPhase 2Peking Union Medical College HospitalNCT07829705Written as 11C-PIB
- A Study of Imaging in Demyelinating DiseasesEnrolling by invitationPhase 2Mayo ClinicNCT05805839Written as C11 Pittsburgh Compound B
- Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal StudyRecruitingNot applicableMayo ClinicNCT02740634Written as C-11 PiB
- Imaging of Brain Amyloid Plaques in the Aging PopulationEnrolling by invitationPhase 4Mayo ClinicNCT00950430Written as Pittsburgh Compound B (C-11 PiB)
- NFL LONG Prospective StudyActive, not recruitingPhase 1University of North Carolina, Chapel HillNCT04263337Written as [11C] PiB
- Quantitative Imaging of Brain Glymphatic Function in HumansActive, not recruitingEarly Phase 1Vanderbilt University Medical CenterNCT04768101Written as [11C]-PIB
- [C-11]PiB PET Imaging in Alcohol Use DisordersCompletedEarly Phase 1University of PittsburghNCT03746366Written as Pittsburgh Compound B
- PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) RadioligandTerminatedPhase 1National Institute of Mental Health (NIMH)NCT03958630Written as 11C-PIB
- Brain Imaging in the Diabetes Prevention Program Outcomes StudyTerminatedEarly Phase 1José A. LuchsingerNCT03757910Written as 11C-PIB
- PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy VolunteersCompletedPhase 1Johns Hopkins UniversityNCT01826110Written as [11C]PIB
- 11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia SyndromesStatus unknownPhase 2Oriental Neurosurgery Evidence-Based-Study TeamNCT03555292Written as 11C-PiB
- Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)CompletedPhase 2Mayo ClinicNCT01607476Written as C11 PiB
- Florbetapir Calibration to the Centiloid ScaleCompletedPhase 1Avid RadiopharmaceuticalsNCT02120664Written as 11C-PiB
- PiB PET Scanning in Speech and Language Based DementiasCompletedPhase 1Mayo ClinicNCT01623284Written as C-11 PiB
- Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical ADCompletedPhase 1Mayo ClinicNCT01723553Written as C-11 PiB
- Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young AdultsCompletedPhase 1Mayo ClinicNCT01609335Written as C-11 PiB